Patent · US Active

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

US11395818B2 · kind B2 · utility

34Cited by

0References

3Claims

0Family size

Assignee

Deciphera Pharmaceuticals, LLC · US

Inventors

Michael D. Kaufman · Waltham, US
Scott Bone · Bend, US
Corey Bloom · Bend, US
Fred Jordan · Bend, US

Key dates

Filing date	Feb 19, 2021
Grant date	Jul 26, 2022
Priority date	—
Expiry date	Feb 19, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are low impurity compositions comprising a compound represented by Formula (I): which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRα kinases, and oncogenic forms thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.